baber/WOPTO huggingface dataset:
Patent DE-69737476-T2 (DE)
Inventor: SHEN SHI-HSIANG
IPC: C07K14/72
Filed: 1997-07-04
Granted: 2007-12-06
Abstract: The present invention is directed to a novel receptor for galanin which has been designated as galanin receptor 2. The invention encompasses both the receptor protein as well as nucleic acids encoding the protein. In addition, the present invention is directed to methods and compositions which rely upon either GAL-R2 proteins or nucleic acids.
Patent DE-69737818-T2 (DE)
Inventor: MECKLENBURG MICHAEL
IPC: G01N33/00
Filed: 1997-06-24
Granted: 2008-03-06
Abstract: Described is a method for discriminating complex biological samples using an array of discrete biological sensing elements immobilized onto a solid support in which constituents bound to the sensor array is directly determined by measuring the mass increase on the surface; data analysis of said method is performed using neutral network or statical based pattern recognition techniques. In a preferred embodiment the liquid sample is tested for the presence of soluble constituent(s) by contacting said sample with said sensor array under specific conditions, removing unbound sample constituent(s), determining the mass increase on the surface and comprising said mass increase data with a reference standard using pattern recognition software.
Patent DE-69737868-T2 (DE)
Inventor: AHMAVAARA KALLE
IPC: H04W24/04
Filed: 1997-12-30
Granted: 2008-03-06
Abstract: The invention relates to a method for a duplex telecommunication connection in radio connections based on a frame-structured interactive communication and a radio system where the frame-structured interactive communication is performed in the radio connections. The invention provides a means for improving the use of channel resources in the implementation of the interactive telecommunication connection by providing a FDD connection with one or more TDD dimensions. The general approach of the invention is that a full-duplex frequency band is time-duplexed into two or more sub-bands in which interactive communication takes place substantially independently. Transmissions in different transmission directions in each sub-band occur at different times, but a simultaneous transmission can take occur in two different sub-bands in different transmission directions. It is an advantage of the invention in interactive communication that the message is received entirely in one transmission direction before it needs to be responded in another transmission direction in a particular sub-band. On the other hand, the frequency band is utilized effectively for communication because transmission can be performed simultaneously in different sub-bands in the reverse transmission directions.
Patent DE-69811404-T2 (DE)
Inventor: SCHIELKE PAUL
IPC: A61P43/00
Filed: 1998-11-20
Granted: 2003-12-04
Abstract: This invention comprises the compound (1) and the pharmaceutically acceptable salts thereof. Compound (1) is an interleukin-1 beta  converting enzyme inhibitor and is useful for treating inflammatory diseases such as arthritis and inflammatory bowel disease, septic shock, reperfusion injury, shigellosis, and neuroinflammatory disorders such as stroke, multiple sclerosis, and Alzheimer's disease.
Patent DE-69825895-T2 (DE)
Inventor: MILET YVES
IPC: H02K3/12
Filed: 1998-06-19
Granted: 2005-09-08
Abstract: The invention concerns a coil (31, 32,38, 39) for a rotating electric machine magnetic circuit (20), comprising two compound magnets (36, 37) and two winding ends (51, 52) the thickness of which is substantially equal to a fraction of said compound magnet thickness, said coil being symmetrical relative to the compound magnet median plane. The coils are arranged adjacent in the magnetic circuit (20) slots and along at least two independent successive coiling layers (24, 25, 26, 27).
Patent DE-69829982-T2 (DE)
Inventor: SCHARSCHMIDT F
IPC: A61P25/28
Filed: 1998-05-06
Granted: 2006-02-23
Abstract: Compositions and methods useful in therapy for IGF-I-responsive conditions in a mammal are provided. The method comprises concurrent therapy with both IGF-I or a variant thereof and at least one GAG to promote a desired therapeutic response with respect to a particular IGF-I- responsive condition. Concurrent therapy is achieved by admininstering to a mammal a single pharmaceutical composition containing both IGF-I (or a variant thereof) and at least one GAG according to a dosing regimen. Alternatively, IGF-I or a variant thereof and at least one GAG can be administered as two separate pharmaceutical compositions. A pharmaceutical composition comprising IGF-I or a variant thereof and at least one GAG for use in the IGF-I and GAG therapy is also provided.
Patent DE-69831485-T2 (DE)
Inventor: MAYER A
IPC: B62D61/02
Filed: 1998-03-17
Granted: 2006-06-01
Abstract: An electric bicycle comprises a frame having a rider seat and propulsion controls positioned and thereon, a settable front wheel having an axle affixed to a front portion of said frame, and a hub spoke rear wheel having an axle with a woven spoke pattern affixed to a rear portion of said frame. A unitary power module, which may be a "kit" for use with a standard bicycle, is used as a propulsion system which includes a battery affixed to said bicycle, and an electric motor having a pinion sprocket affixed thereon. The electric motor is suitable to be connected to the battery by a battery cable. The unitary power module includes a target sprocket and a mounting frame, with the target sprocket comprising a disk shaped assembly having an center opening to allow the unitary member to be placed about the wheel axle. The target sprocket mates to the wheel pattern of either of the wheels to enable target sprocket to be concentrically attached to the wheel by engagement with the wheel by securing elements. The mounting frame is aligned with and rotatably attached to the target sprocket to allow for aligned rotation of the target sprocket about said wheel axle. The mounting frame is attached to the unitary member by a bearing or the like and has an opening to receive the electric motor to enable a pinion sprocket to engage the target sprocket to rotate the rear wheel upon application by the rider of the propulsion controls. A free wheel clutch is provided on the unitary power module or target sprocket to allow the wheel to rotate faster than the motor without motor drag. In this manner, a self-aligned unitary power module is provided by the mounting frame maintaining a single point of reference for aligning the pinion sprocket with the target sprocket.
Patent DE-69902332-T2 (DE)
Inventor: BOIS GEORGES
IPC: B31B19/90
Filed: 1999-05-04
Granted: 2003-02-13
Abstract: A method for automatically making bags equipped with matching closure profiles comprising the steps of: unwinding a supply of at least a film for forming the bag walls; unwinding a supply of closure assembly comprising a W-shaped support sheet, constituting an inner U-shaped tear band provided on its inner surface opposite respectively the matching closure profiles, and the external lateral webs extending beyond the closure profiles and the U-shaped inner band, the closure assembly being further pre-equipped with a series of sliders actuating the closure profiles distributed over the length of the unwinding closure assembly; and fixing the resulting closure assembly via the external lateral webs on the film forming the bag walls.
Patent DE-69904198-T2 (DE)
Inventor: STEPHENSON J
IPC: C02F3/12
Filed: 1999-08-05
Granted: 2003-11-20
Abstract: A process for liquefying microorganisms present in biosolids, such as waste activated sludge, generated by municipal or industrial wastewater treatment plants is disclosed. The process includes the step of passing a slurry of the sludge at a high pressure through a nozzle having a restricted flow area to cause liquefication of the microorganisms as they are discharged from the nozzle. The pressure drop across the nozzle preferably exceeds 5,000 psi. At least part of the liquefied microorganisms may be recirculated to the treatment facility to feed nutrients to the wastewater treatment process. Optionally, the liquefied microorganisms may be anaerobically converted to methane and carbon dioxide. For optimum results, the sludge is subjected to pH adjustment and/or maceration prior to being pumped through the high pressure nozzle.
Patent DE-69908576-T2 (DE)
Inventor: RICHARDSON CHRISTOPHER
IPC: F16L3/10
Filed: 1999-01-26
Granted: 2004-04-22
Abstract: A connecting device for securing a down pipe to a wall comprises a first part fixable to the surface and a second part attachable to the first part and forming an at least partial enclosure for the pipe, the attachment of the second part to the first part being selectively adjustable, whereby spacing of the pipe from the wall is adjustable. Co-operative formations prevent slidable movement of the second part relative to the first part, in a given direction along the longitudinal axis of the pipe, but permit slidable movement of the second part relative to the first part in an opposite direction, along the longitudinal axis of the pipe, once the second part has been slidably attached to the first part.
Patent DE-69914169-T2 (DE)
Inventor: DREYFUS DOMINIQUE
IPC: D21H23/26
Filed: 1999-12-22
Granted: 2004-06-17
Abstract: Preparation of paper with anti-slip properties comprises:  (i) conventional preparation of paper in a machine;  (ii) pre-drying the paper;  (iii) coating both sides with a viscous composition having anti-slip properties while the paper is still warm; and  (iv) passing the paper to the post-drying stage.  An Independent claim is also included for anti-slip paper prepared using a viscous coating composition (A) that contains starch, capsules of gas trapped in a thermoplastic polymer, ammonia, a latex-based binder, an inhibitor, wax and/or talc and water.
Patent DE-69914932-T2 (DE)
Inventor: STEIDLER LOTHAR
IPC: A61K35/74
Filed: 1999-10-06
Granted: 2004-12-09
Abstract: An administration strategy for the delivery at the intestinal mucosa of cytokines or cytokine antagonists, preferably of acid sensitive anti-inflammatory agents, such as IL10 and/or soluble TNF receptor via the oral route. Preferably, inoculation occurs along with a suspension of recombinant Lactococcus lactis cells, which had been engineered to produce the respective proteins.
Patent DE-69921118-T2 (DE)
Inventor: GEREMIA ERNESTO
IPC: A61K31/42
Filed: 1999-05-07
Granted: 2006-02-02
Abstract: 3-Substituted-5-Aryl-4-Isoxazolecarboritriles having anti-viral activity.
Patent DE-69922026-T2 (DE)
Inventor: DARGENT JEROME
IPC: A61F5/00
Filed: 1999-09-14
Granted: 2005-12-08
Abstract: Constriction device (1) which can be at least partially implanted in the human or animal body, comprising a constriction member (2) forming a ring in its operational configuration, said constriction member including a flexible band (12), of which the two ends (12a, 12b) are adjacent to one another in the operational configuration, and a means (3) for actuating the constriction member, characterized in that, in cooperation, on the one hand, at least one end (12b) of the flexible band (12) includes a tractile element (13) for moving said end relative to the other end (12a), generating a radial deformation of the constriction member, and, on the other hand, the actuating means (3) comprises a member (25) for pulling the tractile element (13).
Patent DE-69922131-T2 (DE)
Inventor: STEINER MITCHELL S
IPC: A61P35/00
Filed: 1999-05-07
Granted: 2005-11-24
Abstract: The invention relates to the chemoprevention of prostate cancer and, more particularly, provides a chemopreventive agent, e.g. toremifene citrate, for use in treating prostate intraepithelial neoplasia (PIN), especially high grade prostate intraepithelial neoplasia (HGPIN).
Patent DE-69922808-T2 (DE)
Inventor: LEONE ENZO
IPC: A61K31/475
Filed: 1999-09-21
Granted: 2005-12-08
Abstract: Therapeutic compositions having antiviral activity, comprising as active principle yohimbine or its pharmacologically acceptable salts.
Patent DE-69932610-T2 (DE)
Inventor: REILEY A
IPC: A61F2/30
Filed: 1999-04-06
Granted: 2006-11-30
Abstract: A tubular member is sized and configured to establish an access path to bone having an interior volume occupied, at least in part, by cancellous bone. The tubular member includes a distal end portion having at least one opening. A structure is sized and configured to be carried by the tubular member and controllably advanced through the at least one opening to define a cutting surface that projects outside the distal end portion. The cutting surface has a dimension capable of cutting cancellous bone in response to rotation of the tubular member within the cancellous bone.
Patent DE-69935029-T2 (DE)
Inventor: PRASAD VIDYANATHA A
IPC: C07B61/00
Filed: 1999-09-06
Granted: 2007-07-12
Abstract: The present invention provides a process for making thiadiazole sulfones. In particular, the present process is used to make 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole using catalytic oxidation in the presence of a suitable oxidizing agent. The catalyst system used for the oxidation reaction is a mixture of glacial acetic acid and a tungsten catalyst. The tungsten catalyst is preferably selected from the group consisting of sodium tungstate, potassium tunstate, and tungstic acid.
Patent SI-1931316-T2 (SI)
Title: Controlled release pharmaceutical compositions for acid labile drugs
Inventor: SHLIEOUT GEORGE
IPC: A61K38/00
Filed: 2006-08-15
Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
Patent TR-200000337-T2 (TR)
Title: Kinazı harekete geçiren bağımlı siklin protein kinazları, ve bunların kullanımları.
Inventor: FAYE GERARD
IPC: A61P31/04
Filed: 1998-08-11
Abstract: Bulus, takip eden ortak özelliklere sahip bulunan protein-kinazlari'nin ailesi ile ilgili bulunmaktadir: bunlar, genel, mukavamat modeli GxGx(Y/F)GxV'den mahrum bulunmaktadirlar; bunlar, bagimli bir siklin- olmayan CAK tesiri'ne sahip bulunmaktadirlar. Bu familya' nin protein-kinazlari 'nin önleyicileri, küf öldürücüler olarak kullanilabilmektedirler.
Patent TR-200000893-T2 (TR)
Title: Diferansiyasyonlu presleme prosesi.
Inventor: HERBST HARALD
IPC: B30B15/06
Filed: 1998-09-22
Abstract: Bir kavitede hacim deplasmani sureti ile plastik maddelerin süreksiz bir biçimde sekillendirilmesine yönelik bir proses olup, bu proseste sekillendirilecek olan malzemeye sekillendirme enerjisinin verilmesi kative sathinin hareketli en az iki parçasi vasitasi ile yapilir, bir veya daha fazla parça ihtiva eden en az bir kalip yarisi buna nisbetle hareket ettirilir, ve sekillendirme enerjisinin hiç olmazsa bir kismi bu parçalarin nisbi hareketi ile verilir ve kavite sathinin sadece bir kismi sekillendirme enerjisinin verilmesinde rol oynar, ve de prosesin ifasina yönelik bir düzenek ve proses ile veya düzenekte üretilen komponentler de tarif edilmektedir.
Patent TR-200003472-T2 (TR)
Title: Yeni 2-alkil ikameli imidazol bileşikler
Inventor: ADAMS JERRY L
IPC: A61P7/02
Filed: 1999-05-20
Abstract: Bu bulus, 2-pozisyonunda  ikameli imidazol bilesikleri, bunlarin hazirlanmasi için prosesler, bunlarin CSBP kaynakli hastaliklarin tedavisi ve böyle bir terapide farmasötik terkiplerle ilgilidir.
Patent TR-200100765-T2 (TR)
Title: Kemoterapik maddeyle anjiyojen-inhibitörü içeren farmasötik terkip
Inventor: JONCZYK ALFRED
IPC: A61P35/00
Filed: 1999-09-09
Abstract: Bulus, siklo-(Arg-Gly-Asp-D-Phe-NMe-Val) ve/veya bunun fizyolojik bakimdan sakincasi bulunmayan bir tuzunu ve en az bir kemoterapik madde ve/veya bunun fizyolojik bakimindan sakincasi bulunmayan tuzlarindan birini ve/veya anjiyojenez inhibitörü ve/veya bunun fizyolojik  bakimindan sakincasi bulunmayan tuzlarindan birini içeren bir farmasötik terkibi konu almaktadir.
Patent TR-200102232-T2 (TR)
Title: Psödomonik asit kompleksi içeren kültür ortamından psödomonik asit A'nın izole edilmesi için işlem.
Inventor: BARTA ISTVAN
IPC: C12R1/38
Filed: 2000-02-03
Abstract: Pseudumonas bakteri cinsinin psödomonik asit A üreten türevlerinden birinin kültür ortamindan farmasötik kalitede psödomonik asit A antibiyotiginin izolasyonu için, klorlu bir alifatik hidrokarbon veya izobütil asetatla asidik pH'de kültür ortamindan biyosentezlenmis psödomonik asit A'nin ekstraksiyonuna, ardindan saflatirilmasina dayanan bir islem açiklanmaktadir. Bulus izole edilmis psödomonik asit A'nin saflastirilmasi için islemleri de kapsamaktadir.
Patent TR-200102395-T2 (TR)
Inventor: SIDDURI ACHYTHARAO
IPC: A61K31/67
Filed: 2000-02-12
Abstract: New Phenylalaninol derivatives (I). Phenylalaninol derivatives of formula (I) are new: [Image] X : a benzamide group of formula (i), a heterocyclyl-amide group of formula (ii) or an imidazolin-3-yl-4-one group of formula (iii): [Image] R 15halo, NO 2, CN, lower alkylsulfonyl, lower alkyl, lower alkoxy, lower alkoxycarbonyl, carboxy, lower alkylaminosulfonyl, lower perfluoroalkyl, lower alkylthio, lower hydroxyalkyl, alkoxy-lower alkyl, alkylthio-lower alkyl, alkylsulfinyl-lower alkyl, alkylsulfonyl-lower alkyl, lower alkylsulfinyl, lower alkanoyl, aroyl, aryl or aryloxy; R 16H, halo, NO 2, CN, lower alkyl, OH lower perfluoroalkyl or lower alkylthio; Het : 5-6 membered heteroaryl containing 1-2 N, O or S; or 9-10 membered bicyclic heteroaryl containing 1-4 O, S or N; R 30H or lower alkyl; p : 0-1; R 18aryl or heteroaryl; R 19optionally substituted lower alkyl, aryl, heteroaryl, aralkyl or heteroaralkyl; R 20lower alkanoyl or aroyl; Y : a group of formula (iv) or (v) or a 5-6 membered heteroaryl, bonded via C and containing 1-3 O, N or S and optionally substituted by 1-2 lower alkyl, cycloalkyl, halo, CN, perfluoroalkyl or aryl, provided that at least one of the substituents is adjacent to the bonding C; [Image] a : an optional double bond; R 22, R 23H, lower alkyl, lower alkoxy, lower cycloalkyl, aryl aralkyl, NO 2, CN, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, lower alkanoyl, halo or perfluoro lower alkyl; provided that at least one is not H; R 24H, lower alkyl, lower alkoxy, aryl, NO 2, CN, lower alkylsulfony or halo; R 25lower alkyl, lower alkenyl (optionally fluorinated) or R 26(CH 2) e; R 26aryl, heteroaryl, N 3, CN, OH, lower alkoxy. lower alkoxycarbonyl, lower alkanoyl, lower alkylthio, lower alkylsulfonyl, lower alkylsulfinyl, perfluoro-lower alkanoyl, NO 2 or NR 28R 29; R 28H or lower alkyl; R 29H, lower alkyl, lower alkoxycarbonyl, lower alkanoyl, aroyl, perfluoro lower alkanoylamino, lower alkylsulfonyl, lower alkylaminocarbonyl or arylaminocarbonyl; or R 28 + R 294-6 membered carbocyclic ring optionally containing 1 O, N or S and optionally substituted on C by lower alkyl or halo; Q : (CH 2) fO, (CH 2) fS, (CH 2) fN(R 27), (CH 2) f or a bond; R 27H, lower alkyl, aryl, lower alkanoyl, aroyl or lower alkoxycarbonyl; e : 0-4; and f : 1-3. An independent claim is included for preparation of (I). ACTIVITY : Antirheumatic; antiarthritic; antiasthmatic; antiinflammatory; neuroprotective. MECHANISM OF ACTION : (I) inhibit the binding of vascular cell adhesion molecule-1 (VCAM1) and fibronectin to the integrin VLA-4 (not defined) on circulating lymphocytes, eosinophils, basophils and monocytes.
Patent TR-200200140-T2 (TR)
Title: Termik rezonans görüntüleme yöntemi.
Inventor: RINGERMACHER HARRY ISRAEL
IPC: G01B21/08
Filed: 2000-06-13
Abstract: Bir enfraruj (IR) geçici termografi sisteminde, bir IR hassas, odak düzlemi tertibine sahip bir kameradan bir dizi görüntü karesi elde edilir. Ardisik olarak elde edilen her görüntü karesi, piksellerin meydana getirdigi bir tertipten olusur ve geçen zamana karsilik gelen tahsis edilmis bir kare sayisina sahiptir. Ardisik görüntü karelerinin olusturdugu kümelerden, her piksele karsilik gelen zamana karsi sicakli (T-t) verileri elde edilir. Bir objenin kalinliginin saptanmasi ve renkli olarak isaretlenmis veya gri ölçekli olarak kodlanmis bir kalinlik haritasinin üretilmesi için her pikselden alinan normallestirilmis T-t verileri egrisinin bir hizli fourier dönüskesi'nin gerçek ve sanal bilesen kisimlarinin kullanilmasiyla, termik veri görüntü karelerinden olusan kümelerin analiz edilmesi için bir yöntem de sunulmustur.
Patent DE-602004002667-T2 (DE)
Inventor: ROVERS ARNOLDUS MAARTEN MARIA
IPC: B01F15/02
Filed: 2004-12-06
Granted: 2007-08-16
Abstract: A device 1 has a carousel 3 in which there are a number of vertically placed storage cylinders 5. Each storage cylinder 5 is provided with a flange 11 that rests on a support, which is a disc 7, and is fastened by one bolt 13 to the disc. A drive unit 17 rotates the carousel 3. <??>The device has a means of dosing for taking substances from the storage cylinders 5. The means of dosing comprises an additional drive unit 27, which can be coupled to the screw spindles 19 situated in the storage cylinders. The screw spindles 19 are coupled to bars 23, which are situated at their upper ends near the tops of the storage cylinders 5 and are provided with a means of coupling 25. By rotating the carousel 3 each storage cylinder 5 can be brought under the additional drive unit 27. <??>Furthermore, the means of dosing has an electronic scales 33 that is situated under the carousel 3 and a control unit coupled to it, which in turn is coupled to the additional means of driving 27. <IMAGE>
Patent DE-602004003633-T2 (DE)
Inventor: LEE DONG-HYUN
IPC: G06K19/07
Filed: 2004-05-17
Granted: 2007-04-05
Abstract: A radio frequency identification (RF-ID) system sending additional signals; the radio frequency identification (RF-ID) system includes a tag portion (200) including a sensor (220), the tag portion for outputting a composite signal including additional data from the sensor and basic data necessary for certification, an antenna for receiving the composite signal output from the tag portion, and a RF-ID reader portion (250) for retrieving the composite signal received from the antenna and for decoding the basic data and the additional data. <IMAGE>
Patent DE-602004004300-T2 (DE)
Inventor: CHRISTENSEN YANN ERIK
IPC: H04L29/08
Filed: 2004-03-24
Granted: 2007-06-06
Abstract: Methods, systems, and computer program products for abstracting processing layers within a messaging infrastructure so that changes or enhancements can be made to the infrastructure while retaining existing functionality. Message transport implementations are abstracted within a message layer, allowing other layers within the infrastructure to interact with messages in a more generic fashion, largely independent of message transport. Transport examples include named pipes, Transmission Control Protocol (TCP), HyperText Transfer Protocol (HTTP), Simple Mail Transfer Protocol (SMTP), etc. A channel layer above the message layer abstracts message exchange implementations, allowing other layers within the infrastructure to send and receive messages in a more generic fashion, largely independent of the message exchange semantics of a specific implementation. Message exchange examples include datagrams, dialogs, monologs, queues, and the like. Above the channel layer and message layer, a service layer abstracts the binding implementations that bind message exchange implementations to user code implementations. <IMAGE>
Patent DE-602004005146-T2 (DE)
Inventor: VAN ACKER KATLEEN PEGGIE FLORI
IPC: H04L12/28
Filed: 2004-01-06
Granted: 2007-11-15
Abstract: The physical layer session resource broker (PHY SRB) according to the invention receives request from application servers (VOD SERVER, TV BRDCST SERVER, GAME SERVER, WEB SERVER) which are translated into physical layer parameter values. The physical layer parameter values are imposed on the access nodes (DSLAM) by the physical layer session resource broker (PHY SRB). <IMAGE>